HomeSearchTranslational Lung Cancer Research

Translational Lung Cancer Research

AME Publishing Company · Hong Kong · Est. 1929

ISSN2226-4477
SJR Q2WOS SCIEScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q2
SJR · Scopus
Top 50% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.987
H-Indexi
77
SNIPi
0.985
Total Worksi
2,597
Total Citationsi
39,789
2yr Mean Citednessi
1.94
Open Impact Factor alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

Subject areas: Oncology; Respiratory System.

General Information

Country / RegionHong Kong
Primary LanguageEnglish
1st Year Published1929
Annual Volume~ 333 articles / year
StatusActive (last: 2026)
Total Publications2,597
Publisher OrgAME Publishing Company
OA Since2018
Visit Journal Website

Submission Info

Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/11 · 55%
Do you know the journal / publisher?
AME Publishing Company
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2226-4477
Indexed in a trusted database?
WoS, Scopus, PubMed
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
189
5.5k
2019
302
6.7k
2020
389
8.6k
2021
233
3.3k
2022
244
2k
2023
324
1.5k
2024
430
892
2025
266
37
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Subject Classification

Web of Science Categories

OncologyRespiratory System

Scopus Categories

Oncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingCancer Genomics and DiagnosticsPleural and Pulmonary DiseasesFerroptosis and cancer prognosisOccupational and environmental lung diseasesHepatocellular Carcinoma Treatment and Prognosis

Frequently asked questions about Translational Lung Cancer Research

Is Translational Lung Cancer Research a predatory journal?

PubScope has no integrity flags on record for Translational Lung Cancer Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Translational Lung Cancer Research?

Translational Lung Cancer Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.94.

Is Translational Lung Cancer Research indexed in Scopus and Web of Science?

Translational Lung Cancer Research is indexed in Web of Science, Scopus.

What is the aims and scope of Translational Lung Cancer Research?

Subject areas: Oncology; Respiratory System.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref